{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:26:55Z","timestamp":1793867215764,"version":"4.6.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473187"],"award-info":[{"award-number":["82473187"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.acra.2026.07.055","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:34:11Z","timestamp":1790890451000},"page":"5523-5537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine Learning-driven Prognostic Stratification in Metastatic Breast Cancer Using Dynamic 18F-FDG PET\/CT: A Multidimensional Study Integrating Pathomics and Plasma Proteomics"],"prefix":"10.1016","volume":"33","author":[{"given":"Shukai","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushuai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiewei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daojia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0749-568X","authenticated-orcid":false,"given":"Chuangui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2026.07.055_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.acra.2026.07.055_bib2","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(24)00747-5","article-title":"The lancet breast cancer commission","volume":"403","author":"Coles","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.acra.2026.07.055_bib3","unstructured":"World Health Organization (2023) Breast Cancer. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer. 20 Jan 2025."},{"key":"10.1016\/j.acra.2026.07.055_bib4","unstructured":"American Cancer Society. Breast cancer statistics. https:\/\/cancerstatisticscenter.cancer.org\/types\/breast. 20 Jan 2025."},{"key":"10.1016\/j.acra.2026.07.055_bib5","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.02222","article-title":"Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer","volume":"41","author":"Plichta","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acra.2026.07.055_bib6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/SLA.0000000000004231","article-title":"A novel staging system for De Novo metastatic breast cancer refines prognostic estimates","volume":"275","author":"Plichta","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.acra.2026.07.055_bib7","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s43018-021-00229-1","article-title":"Understanding and overcoming tumor heterogeneity in metastatic breast cancer treatment","volume":"2","author":"Pasha","year":"2021","journal-title":"Nat Cancer"},{"key":"10.1016\/j.acra.2026.07.055_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41571-020-00457-x","article-title":"Liquid biopsy enters the clinic - implementation issues and future challenges","volume":"18","author":"Ignatiadis","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.acra.2026.07.055_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13014-023-02231-6","article-title":"PET\/CT standardized uptake value and EGFR expression predicts treatment failure in nasopharyngeal carcinoma","volume":"18","author":"Fei","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.acra.2026.07.055_bib10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13058-023-01722-4","article-title":"Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer","volume":"25","author":"Kazerouni","year":"2023","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.acra.2026.07.055_bib11","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221180","article-title":"FDG PET\/CT prognostic markers in patients with advanced melanoma treated with Ipilimumab and Nivolumab","volume":"307","author":"Iravani","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2026.07.055_bib12","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00259-020-04757-3","article-title":"Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4","volume":"47","author":"Seban","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.acra.2026.07.055_bib13","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1634\/theoncologist.2018-0001","article-title":"Pretreatment (18)F-FDG uptake heterogeneity predicts treatment outcome of first-line chemotherapy in patients with metastatic triple-negative breast cancer","volume":"23","author":"Gong","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.acra.2026.07.055_bib14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s00259-024-06929-x","article-title":"Pre-treatment [18F]FDG PET\/CT biomarkers for the prediction of antibody-drug conjugates efficacy in metastatic breast cancer","volume":"52","author":"Seban","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.acra.2026.07.055_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40644-023-00608-0","article-title":"Pretreatment (18)F-FDG uptake heterogeneity may predict treatment outcome of combined Trastuzumab and Pertuzumab therapy in patients with metastatic HER2 positive breast cancer","volume":"23","author":"Ma","year":"2023","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.acra.2026.07.055_bib16","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.3390\/cancers14163973","article-title":"Temporal heterogeneity of HER2 expression and spatial heterogeneity of (18)F-FDG uptake predicts treatment outcome of pyrotinib in patients with her2-positive metastatic breast cancer","volume":"14","author":"Gong","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.acra.2026.07.055_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2967\/jnumed.121.263358","article-title":"Response monitoring in metastatic breast cancer: a prospective study comparing (18)F-FDG PET\/CT with conventional CT","volume":"64","author":"Vogsen","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.acra.2026.07.055_bib18","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2967\/jnumed.112.119271","article-title":"18F-FDG PET\/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO","volume":"54","author":"Gebhart","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.acra.2026.07.055_bib19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1109\/TMI.2020.3021387","article-title":"Pathomic fusion: an integrated framework for fusing histopathology and genomic features for cancer diagnosis and prognosis","volume":"41","author":"Chen","year":"2022","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1016\/j.acra.2026.07.055_bib20","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ccell.2022.09.012","article-title":"Artificial intelligence for multimodal data integration in oncology","volume":"40","author":"Lipkova","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.acra.2026.07.055_bib21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s43018-020-0085-8","article-title":"Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis","volume":"1","author":"Fu","year":"2020","journal-title":"Nat Cancer"},{"key":"10.1016\/j.acra.2026.07.055_bib22","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.7150\/thno.62187","article-title":"CST6 protein and peptides inhibit breast cancer bone metastasis by suppressing CTSB activity and osteoclastogenesis","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.acra.2026.07.055_bib23","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1158\/0008-5472.CAN-20-3328","article-title":"Fam20C regulates bone resorption and breast cancer bone metastasis through osteopontin and BMP4","volume":"81","author":"Zuo","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.acra.2026.07.055_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65477-6","article-title":"Integrated spatial proteomic analysis of breast cancer heterogeneity unravels cancer cell phenotypic plasticity","volume":"16","author":"Mardamshina","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.acra.2026.07.055_bib25","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1097\/JS9.0000000000002999","article-title":"Molecular characterization of breast cancer and multiple primary malignancies: the latest application using unmarked quantitative proteomics","volume":"111","author":"Wang","year":"2025","journal-title":"Int J Surg"},{"key":"10.1016\/j.acra.2026.07.055_bib26","doi-asserted-by":"crossref","first-page":"m441","DOI":"10.1136\/bmj.m441","article-title":"Calculating the sample size required for developing a clinical prediction model","volume":"368","author":"Riley","year":"2020","journal-title":"Bmj"},{"key":"10.1016\/j.acra.2026.07.055_bib27","first-page":"2495","article-title":"New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)","volume":"36","author":"Watanabe","year":"2009","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.acra.2026.07.055_bib28","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.acra.2026.07.055_bib29","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1634\/theoncologist.2019-0561","article-title":"The predictive value of early changes in (18) F-fluoroestradiol positron emission tomography\/computed tomography during fulvestrant 500 mg therapy in patients with estrogen receptor-positive metastatic breast cancer","volume":"25","author":"He","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.acra.2026.07.055_bib30","unstructured":"Lundberg, S., and Lee, S.I. (2017). A Unified Approach to Interpreting Model Predictions."},{"key":"10.1016\/j.acra.2026.07.055_bib31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s11523-018-0596-8","article-title":"Everolimus exposure and early metabolic response as predictors of treatment outcomes in breast cancer patients treated with everolimus and exemestane","volume":"13","author":"Willemsen","year":"2018","journal-title":"Target Oncol"},{"key":"10.1016\/j.acra.2026.07.055_bib32","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.2967\/jnumed.118.211102","article-title":"Prospective study of serial (18)F-FDG PET and (18)F-fluoride PET to predict time to skeletal-related events, time to progression, and survival in patients with bone-dominant metastatic breast cancer","volume":"59","author":"Peterson","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.acra.2026.07.055_bib33","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.pan.2023.04.009","article-title":"Machine learning versus regression for prediction of sporadic pancreatic cancer","volume":"23","author":"Chen","year":"2023","journal-title":"Pancreatology"},{"key":"10.1016\/j.acra.2026.07.055_bib34","doi-asserted-by":"crossref","first-page":"10114","DOI":"10.1038\/s41598-026-40565-9","article-title":"A comparative analysis of data-driven models for breast cancer survival prediction","volume":"16","author":"Takele","year":"2026","journal-title":"Sci Rep"},{"key":"10.1016\/j.acra.2026.07.055_bib35","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12885-025-13663-6","article-title":"Survival machine learning model of T1 colorectal postoperative recurrence after endoscopic resection and surgical operation: a retrospective cohort study","volume":"25","author":"Li","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.acra.2026.07.055_bib36","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1186\/s12885-020-07449-1","article-title":"A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study","volume":"20","author":"Zhao","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.acra.2026.07.055_bib37","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1002\/cam4.1224","article-title":"Development and validation of a nomogram predicting the overall survival of stage IV breast cancer patients","volume":"6","author":"Li","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.acra.2026.07.055_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41523-023-00574-7","article-title":"Radiomic predicts early response to CDK4\/6 inhibitors in hormone receptor positive metastatic breast cancer","volume":"9","author":"Khorrami","year":"2023","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.acra.2026.07.055_bib39","article-title":"18)F-FDG PET\/CT radiomics signature and clinical parameters predict progression-free survival in breast cancer patients: a preliminary study","volume":"13","author":"Xu","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.acra.2026.07.055_bib40","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/s41591-025-03630-w","article-title":"Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial","volume":"31","author":"Yin","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.acra.2026.07.055_bib41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2203690","article-title":"Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer","volume":"387","author":"Modi","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acra.2026.07.055_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1200\/JCO.24.00920","article-title":"Datopotamab deruxtecan versus chemotherapy in previously treated inoperable\/metastatic hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer: primary results from TROPION-breast01","volume":"43","author":"Bardia","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acra.2026.07.055_bib43","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.acra.2026.07.055_bib44","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S1470-2045(17)30899-9","article-title":"Chromatin organisation and cancer prognosis: a pan-cancer study","volume":"19","author":"Kleppe","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.acra.2026.07.055_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1129162","article-title":"A functional genetic screen for metabolic proteins unveils GART and the de novo purine biosynthetic pathway as novel targets for the treatment of luminal A ER\u03b1 expressing primary and metastatic invasive ductal carcinoma","volume":"14","author":"Cipolletti","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.acra.2026.07.055_bib46","article-title":"Enzymatic and microenvironmental regulation in adenosine metabolism-mediated immunosuppression","volume":"16","author":"Li","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.acra.2026.07.055_bib47","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1038\/s41467-023-37727-y","article-title":"Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer","volume":"14","author":"Palakurthi","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.acra.2026.07.055_bib48","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coi.2015.12.007","article-title":"The urgent need to recover MHC class I in cancers for effective immunotherapy","volume":"39","author":"Garrido","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.acra.2026.07.055_bib49","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T cell dysfunction in cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226005647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226005647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:49:09Z","timestamp":1793864949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633226005647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1076633226005647"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2026.07.055","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Machine Learning-driven Prognostic Stratification in Metastatic Breast Cancer Using Dynamic 18F-FDG PET\/CT: A Multidimensional Study Integrating Pathomics and Plasma Proteomics","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2026.07.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Association of Academic Radiology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}